• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减重手术后的药物管理:提供最佳患者护理。

Medication Management after Bariatric Surgery: Providing Optimal Patient Care.

作者信息

Porat Daniel, Dahan Arik

机构信息

Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

出版信息

J Clin Med. 2020 May 17;9(5):1511. doi: 10.3390/jcm9051511.

DOI:10.3390/jcm9051511
PMID:32429592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7290848/
Abstract

Substantially altered gastrointestinal anatomy/physiology after bariatric surgery presents new challenges for the proper medication management of these patients; drug absorption and bioavailability may increase, decrease, or remain unchanged post surgery, depending on the specific drug in question and the type of bariatric procedure. In this article, we offer a concise overview of the various aspects of this clinically significant issue, aiming to provide readers with a clear understanding as well as practical tools to handle drug management post bariatric surgery. Realizing the potentially altered pharmacokinetics of various drugs after bariatric surgery is essential for providing optimal pharmacological therapy and overall patient care.

摘要

减肥手术后胃肠道解剖结构/生理功能发生显著改变,给这些患者的合理药物管理带来了新挑战;术后药物吸收和生物利用度可能增加、降低或保持不变,这取决于所涉及的具体药物和减肥手术的类型。在本文中,我们简要概述了这个具有临床意义的问题的各个方面,旨在为读者提供清晰的理解以及处理减肥手术后药物管理的实用工具。认识到减肥手术后各种药物潜在的药代动力学改变对于提供最佳药物治疗和全面的患者护理至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc11/7290848/0f9e4d81c675/jcm-09-01511-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc11/7290848/0f9e4d81c675/jcm-09-01511-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc11/7290848/0f9e4d81c675/jcm-09-01511-g001.jpg

相似文献

1
Medication Management after Bariatric Surgery: Providing Optimal Patient Care.减重手术后的药物管理:提供最佳患者护理。
J Clin Med. 2020 May 17;9(5):1511. doi: 10.3390/jcm9051511.
2
Treatment of COVID-19 Patients Post-Bariatric Surgery: Issues for Consideration.肥胖症手术后新冠肺炎患者的治疗:需考虑的问题。
J Clin Med. 2020 Aug 31;9(9):2827. doi: 10.3390/jcm9092827.
3
A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution.一种评估病态肥胖患者减肥手术后改良口服药物生物利用度的机制药代动力学模型:CYP3A 肠壁代谢、通透性和溶解之间的相互作用。
J Pharm Pharmacol. 2012 Jul;64(7):1008-24. doi: 10.1111/j.2042-7158.2012.01538.x.
4
Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations.减重手术后的口服药物治疗:基础、文献及临床建议概述
Obes Rev. 2016 Nov;17(11):1050-1066. doi: 10.1111/obr.12434. Epub 2016 Jun 22.
5
Medication and nutrient administration considerations after bariatric surgery.减肥手术后的药物和营养管理注意事项。
Am J Health Syst Pharm. 2006 Oct 1;63(19):1852-7. doi: 10.2146/ajhp060033.
6
[DRUG THERAPY FOLLOWING BARIATRIC SURGERY: EXAMINATION OF POTENTIAL IMPACT AND CLINICAL RECOMMENDATIONS].[减重手术后的药物治疗:潜在影响及临床建议探讨]
Harefuah. 2017 Jan;156(1):31-37.
7
Managing the Unpredictable: Mechanistic Analysis and Clinical Recommendations for Lamotrigine Treatment after Bariatric Surgery.应对不可预测的情况:减肥手术后拉莫三嗪治疗的机制分析与临床建议
J Clin Med. 2021 Nov 29;10(23):5627. doi: 10.3390/jcm10235627.
8
RYGB and Drug Disposition: How to Do Better? Analysis of Pharmacokinetic Studies and Recommendations for Clinical Practice.胃旁路手术与药物处置:如何做得更好?药代动力学研究分析及临床实践建议。
Obes Surg. 2017 Apr;27(4):1076-1090. doi: 10.1007/s11695-016-2535-z.
9
Altered drug disposition following bariatric surgery: a research challenge.减肥手术后药物处置的改变:一项研究挑战。
Clin Pharmacokinet. 2015 Jun;54(6):573-9. doi: 10.1007/s40262-015-0259-1.
10
Review article: The nutritional and pharmacological consequences of obesity surgery.综述文章:肥胖症手术的营养和药理学后果。
Aliment Pharmacol Ther. 2014 Sep;40(6):582-609. doi: 10.1111/apt.12872. Epub 2014 Jul 30.

引用本文的文献

1
Physiologically Based Pharmacokinetic Modeling for Predicting Drug Levels After Bariatric Surgery: Vardenafil Exposure Before vs. After Gastric Sleeve/Bypass.基于生理的药代动力学模型预测减肥手术后的药物水平:胃袖状切除术/胃旁路术后伐地那非的暴露情况对比
Biomolecules. 2025 Jul 7;15(7):975. doi: 10.3390/biom15070975.
2
Pharmacokinetic Changes in Medications After Bariatric Surgery: A Scoping Review.减肥手术后药物的药代动力学变化:一项范围综述
J Nurse Pract. 2024 Jul-Aug;20(7). doi: 10.1016/j.nurpra.2024.105043. Epub 2024 May 28.
3
Erectile Dysfunction Therapy of Bariatric Patients: Tadalafil Biopharmaceutics and Pharmacokinetics Before vs. After Gastric Sleeve/Bypass.

本文引用的文献

1
Case Report of Increased Exposure to Antiretrovirals following Sleeve Gastrectomy.胃袖状切除术增加抗逆转录病毒药物暴露的病例报告。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02453-19.
2
Increased Paracetamol Bioavailability after Sleeve Gastrectomy: A Crossover Pre- vs. Post-Operative Clinical Trial.袖状胃切除术后对乙酰氨基酚生物利用度增加:一项术前与术后对比的交叉临床试验。
J Clin Med. 2019 Nov 12;8(11):1949. doi: 10.3390/jcm8111949.
3
The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review.
肥胖患者勃起功能障碍治疗:胃袖状切除术/旁路术前与术后他达拉非的生物药剂学和药代动力学对比。
AAPS J. 2024 Nov 14;26(6):114. doi: 10.1208/s12248-024-00985-9.
4
Can Consultation by a Clinical Pharmacist Prevent Morbidity and Mortality in Patients Undergoing Bariatric Surgery?临床药剂师的会诊能否预防肥胖症手术患者的发病和死亡?
J Clin Med. 2024 Jan 5;13(2):310. doi: 10.3390/jcm13020310.
5
Changes in Serum Concentration of Antidepressants After Bariatric Surgery and Recommendations for Postbariatric Surgery Antidepressant Therapy.减重手术后抗抑郁药血清浓度的变化及减重手术后抗抑郁治疗的建议。
J Acad Consult Liaison Psychiatry. 2024 May-Jun;65(3):261-270. doi: 10.1016/j.jaclp.2024.01.001. Epub 2024 Jan 12.
6
Bioavailability of Orally Administered Drugs After Bariatric Surgery.口服药物经减重手术后的生物利用度。
Curr Obes Rep. 2024 Mar;13(1):141-153. doi: 10.1007/s13679-023-00548-7. Epub 2024 Jan 3.
7
The Complexity of Bariatric Patient's Pharmacotherapy: Sildenafil Biopharmaceutics and Pharmacokinetics before vs. after Gastric Sleeve/Bypass.肥胖症患者药物治疗的复杂性:胃袖状切除术/胃旁路术后与术前西地那非的生物药剂学和药代动力学
Pharmaceutics. 2023 Dec 18;15(12):2795. doi: 10.3390/pharmaceutics15122795.
8
The Effects of Bariatric Surgery on Pharmacokinetics of Drugs: a Review of Current Evidence.减重手术对药物药代动力学的影响:当前证据综述。
Curr Nutr Rep. 2023 Dec;12(4):695-708. doi: 10.1007/s13668-023-00498-5. Epub 2023 Oct 20.
9
Bariatric surgery and medicines: from first principles to practice.减肥手术与药物:从基本原则到实践
Aust Prescr. 2022 Oct;45(5):162-166. doi: 10.18773/austprescr.2022.053. Epub 2022 Oct 4.
10
Managing the Unpredictable: Mechanistic Analysis and Clinical Recommendations for Lamotrigine Treatment after Bariatric Surgery.应对不可预测的情况:减肥手术后拉莫三嗪治疗的机制分析与临床建议
J Clin Med. 2021 Nov 29;10(23):5627. doi: 10.3390/jcm10235627.
肥胖患者减重手术对口服药物生物利用度的影响:系统评价。
Obes Rev. 2019 Sep;20(9):1299-1311. doi: 10.1111/obr.12869. Epub 2019 Jun 24.
4
Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects.术后口服左甲状腺素治疗:生物制药方面和临床效果。
Surg Obes Relat Dis. 2019 Feb;15(2):333-341. doi: 10.1016/j.soard.2019.01.001. Epub 2019 Jan 10.
5
Lithium Toxicity with Severe Bradycardia Post Sleeve Gastrectomy: a Case Report and Review of the Literature.胃袖状切除术术后锂中毒伴严重心动过缓:病例报告及文献复习。
Obes Surg. 2019 Feb;29(2):735-738. doi: 10.1007/s11695-018-3597-x.
6
Gut microbiota modulates drug pharmacokinetics.肠道微生物群调节药物的药代动力学。
Drug Metab Rev. 2018 Aug;50(3):357-368. doi: 10.1080/03602532.2018.1497647. Epub 2018 Sep 19.
7
IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures.国际肥胖与代谢病外科联盟2016年全球调查:原发性、腔内及修复性手术
Obes Surg. 2018 Dec;28(12):3783-3794. doi: 10.1007/s11695-018-3450-2.
8
Obesity Management Task Force of the European Association for the Study of Obesity Released "Practical Recommendations for the Post-Bariatric Surgery Medical Management".肥胖管理工作组发布了《减重手术后医疗管理的实用建议》。
Obes Surg. 2018 Jul;28(7):2117-2121. doi: 10.1007/s11695-018-3283-z.
9
Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality.采用腹腔镜束带术、Roux-en-Y胃旁路术或腹腔镜袖状胃切除术的减重手术与常规肥胖管理对全因死亡率的影响。
JAMA. 2018 Jan 16;319(3):279-290. doi: 10.1001/jama.2017.20513.
10
Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management.肥胖管理工作组的实用建议肥胖协会对肥胖症的研究后的医疗管理后的肥胖症的医疗管理。
Obes Facts. 2017;10(6):597-632. doi: 10.1159/000481825. Epub 2017 Dec 6.